Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000553119 | SCV000644455 | likely benign | Tuberous sclerosis 2 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001020707 | SCV001182220 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000553119 | SCV002039345 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491057 | SCV002796520 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-03-14 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999294 | SCV004833167 | likely benign | Tuberous sclerosis syndrome | 2023-05-04 | criteria provided, single submitter | clinical testing |